COVID-19: We keep you up-to-date on the latest developments and their legal implications. All newsletters and updates from our experts in the various practice areas can be found here.

Back to overview

Niederer Kraft & Frey

Main navigation

Sub navigation

Samuel Hochstrasser

Associate, Corporate/M&A, Commercial, Capital Markets

Profile
Experience
News & Insights

Samuel Hochstrasser’s practice focuses on domestic and cross-border M&A, capital markets and private equity transactions. His expertise includes corporate, commercial and contract law. He has particular knowledge of the life sciences sector, advising on regulatory and legal in life science matters.

Experience

Recent matters in which Samuel acted as counsel include:

Landis+Gyr Group and its shareholders Toshiba and INCJ in the dual track exit process resulting in the CHF 2.3 billion IPO of Landis+Gyr Group on SIX, the largest Swiss IPO of the past 10 years and second largest IPO in Europe 2017
Actelion in connection with the public tender offer by Johnson & Johnson to the shareholders of Actelion and in connection with the demerger of Idorsia from Actelion
BioTelemetry, Inc. in connection with its competing public tender offer to the shareholders of LifeWatch AG

Year	Position
2020	Position LL.M., Keio University, Tokyo, Gerald P. McAlinn Price in International and Comparative Law
2016	Position Admitted to the Bar, Rechtsanwalt
2014	Position University of St. Gallen, Master of Arts HSG in Law and Economics
2012	Position University of Texas, School of Law, Exchange Semester
2011	Position University of St. Gallen, Bachelor of Arts HSG in Law and Economics

Swiss Bar Association
Zurich Bar Association
HSG Alumni

Year	Position
2017	Position Associate, Niederer Kraft Frey
2015	Position Clerk with the District Court of Aarau
2014	Position Junior Associate, Niederer Kraft Frey

News & Insights

Back to Overview

Subscribe to our newsletter